Moody Lynn & Lieberson’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$997K Sell
2,753
-9,613
-78% -$3.29M 0.05% 124
2026
Q1
$4.35M Sell
12,366
-689
-5% -$246K 0.24% 54
2025
Q4
$4.27M Buy
13,055
+10,301
+374% +$3.27M 0.23% 61
2025
Q3
$777K Sell
2,754
-37
-1% -$10.7K 0.04% 137
2025
Q2
$779K Sell
2,791
-12,158
-81% -$3.44M 0.05% 136
2025
Q1
$4.66M Buy
14,949
+12,210
+446% +$3.61M 0.3% 54
2024
Q4
$714K Sell
2,739
-580
-17% -$172K 0.04% 142
2024
Q3
$1.07M Sell
3,319
-10,593
-76% -$3.47M 0.07% 124
2024
Q2
$4.35M Buy
13,912
+11,070
+390% +$3.25M 0.28% 55
2024
Q1
$808K Hold
2,842
0.05% 126
2023
Q4
$819K Hold
2,842
0.06% 128
2023
Q3
$764K Sell
2,842
-107
-4% -$26.7K 0.07% 119
2023
Q2
$655K Buy
2,949
+1,270
+76% +$295K 0.05% 133
2023
Q1
$406K Sell
1,679
-11,675
-87% -$2.87M 0.04% 169
2022
Q4
$3.51M Buy
13,354
+11,675
+695% +$3.13M 0.32% 64
2022
Q3
$378K Hold
1,679
0.04% 168
2022
Q2
$409K Buy
1,679
+195
+13% +$47.8K 0.04% 165
2022
Q1
$359K Hold
1,484
0.03% 184
2021
Q4
$334K Hold
1,484
0.02% 198
2021
Q3
$316K Sell
1,484
-20
-1% -$4.6K 0.02% 189
2021
Q2
$367K Sell
1,504
-61
-4% -$15K 0.03% 177
2021
Q1
$389K Buy
1,565
+40
+3% +$9.54K 0.03% 174
2020
Q4
$351K Hold
1,525
0.03% 169
2020
Q3
$388K Hold
1,525
0.04% 150
2020
Q2
$360K Hold
1,525
0.04% 144
2020
Q1
$309 Sell
1,525
-21,574
-93% -$4.71M 0.04% 133
2019
Q4
$5.57M Buy
+23,099
New +$5.09M 0.54% 56
2019
Q1
Sell
-44,467
Closed -$8.66M 187
2018
Q4
$8.66M Buy
44,467
+20,767
+88% +$4.05M 1.16% 28
2018
Q3
$4.91M Buy
23,700
+19,665
+487% +$3.88M 0.52% 61
2018
Q2
$745K Buy
+4,035
New +$714K 0.09% 119
2017
Q4
Sell
-12,620
Closed -$2.35M 208
2017
Q3
$2.35M Buy
+12,620
New +$2.24M 0.29% 71
2017
Q2
Sell
-37,640
Closed -$6.18M 213
2017
Q1
$6.18M Buy
37,640
+7,610
+25% +$1.26M 0.87% 45
2016
Q4
$4.39M Sell
30,030
-33,513
-53% -$5.04M 0.63% 50
2016
Q3
$10.6M Buy
+63,543
New +$10.7M 1.76% 15
2016
Q1
Sell
-46,292
Closed -$7.51M 160
2015
Q4
$7.51M Buy
46,292
+43,493
+1,554% +$6.84M 1.18% 28
2015
Q3
$387K Buy
+2,799
New +$441K 0.07% 129
2015
Q2
Sell
-117,975
Closed -$18.9M 191
2015
Q1
$18.9M Sell
117,975
-1,735
-1% -$273K 3.01% 5
2014
Q4
$19.1M Sell
119,710
-2,903
-2% -$452K 2.72% 4
2014
Q3
$17.2M Buy
122,613
+58,139
+90% +$7.59M 2.56% 6
2014
Q2
$7.63M Buy
64,474
+7,780
+14% +$901K 1.05% 39
2014
Q1
$6.99M Sell
56,694
-3,236
-5% -$392K 1.01% 39
2013
Q4
$6.84M Buy
59,930
+959
+2% +$109K 0.93% 42
2013
Q3
$6.6M Buy
58,971
+17,511
+42% +$1.9M 1.02% 39
2013
Q2
$4.09M Buy
+41,460
New +$4.3M 0.72% 53

Other funds holding AMGN

Moody Lynn & Lieberson's AMGN Position: Q2 2026 in Review

Moody Lynn & Lieberson reduced its Amgen (AMGN) stake by 78% in Q2 2026, selling an estimated $3.29M and leaving 2,753 shares worth $997K. The position accounts for 0.05% of the portfolio, ranked #124.

Moody Lynn & Lieberson first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $19.1M in Q4 2014. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Moody Lynn & Lieberson held 2,753 shares of Amgen worth $997K as of Q2 2026.
  • Moody Lynn & Lieberson sold 9,613 Amgen shares in Q2 2026, an estimated $3.29M.
  • Amgen made up 0.05% of Moody Lynn & Lieberson's portfolio in Q2 2026, its #124 holding.
  • Moody Lynn & Lieberson first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
  • Moody Lynn & Lieberson's Amgen position peaked at $19.1M in Q4 2014.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.